Identifying Epithelial-Cell Progression Signatures (ECPSs) from Multi-Resolution Multi-Omics Data for Translational Clinical Applications in Lung Adenocarcinoma
International Journal of Molecular Sciences · 29.07.2026 · 27 (15) · 6819
DOI: 10.3390/ijms27156819 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.07.2026. Verfasst von Xueyao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Epithelial Cells, Transcriptome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Heilongjiang Provincial Postdoctoral Science Foundation.
Abstract (Originalsprache)
Dynamic transcriptomic remodeling of epithelial cells represents a critical hallmark of lung adenocarcinoma (LUAD) progression, yet epithelial-cell progression signatures (ECPSs) linked to this process remain incompletely characterized, impeding our understanding of malignant LUAD transformation. Here, we performed a multi-resolution multi-omics study and identified two functionally opposing ECPSs: a Cancer-Promoting Signature (CPS) and a Cancer-Suppressing Signature (CSS). The CPS was progressively upregulated from normal to early- and advanced-stage lesions, while the CSS was gradually downregulated, and both were validated by multi-resolution transcriptomic data. Both the CPS and CSS demonstrated robust diagnostic value for LUAD, particularly in early-stage detection (median AUC > 0.95). In seven independent validation cohorts, the CPS and CSS served as robust prognostic risk and protective factors, respectively. Their combination could better stratify LUAD patients into distinct prognostic subgroups, with the CPShigh–CSSlow subgroup showing the worst prognosis, accompanied by high genomic instability, an immunosuppressive tumor microenvironment, and resistance to chemotherapy. Notably, the CPS and CSS exhibited broad translational value in other epithelium-derived cancers. HMGA1, a key CPS gene, showed epithelium- and advanced-stage-specific high expression, which was significantly associated with poor prognosis, genomic instability, and immune escape. Collectively, our study identifies the CPS and CSS as clinically reliable ECPSs, providing valuable biomarkers for clinical application to LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
ORCID-Profile: Yanyan Ping
Förderung
- National Natural Science Foundation of China
- Heilongjiang Provincial Postdoctoral Science Foundation
Zitieren
APA
Chen, X., Lv, T., Wu, Y., Fan, F., Kang, S., Dou, R., Zhang, W., Li, D., Li, R., & Ping, Y. (2026). Identifying Epithelial-Cell Progression Signatures (ECPSs) from Multi-Resolution Multi-Omics Data for Translational Clinical Applications in Lung Adenocarcinoma. International Journal of Molecular Sciences, 27(15), 6819. https://doi.org/10.3390/ijms27156819
Vancouver
Chen X, Lv T, Wu Y, Fan F, Kang S, Dou R, et al. Identifying Epithelial-Cell Progression Signatures (ECPSs) from Multi-Resolution Multi-Omics Data for Translational Clinical Applications in Lung Adenocarcinoma. International Journal of Molecular Sciences. 2026;27(15):6819. doi:10.3390/ijms27156819
BibTeX
@article{Chen2026,
author = {Chen, Xueyao and Lv, Tongxin and Wu, Yang and Fan, Fangfang and Kang, Shaobo and Dou, Renjie and Zhang, Wanmei and Li, Dongxue and Li, Rui and Ping, Yanyan},
title = {Identifying Epithelial-Cell Progression Signatures (ECPSs) from Multi-Resolution Multi-Omics Data for Translational Clinical Applications in Lung Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6819},
doi = {10.3390/ijms27156819}
}
EUVIMED